Definitive Contract 75N93021C00057

Award Date 9/30/21

Potential Completion Date 9/30/23

Potential Value $300K

Federal Agency

National Institute of Allergy and Infectious Diseases

Awardee

Teichos Laboratories, LLC

Ultimate Awardee

Not listed

NAICS Category

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

PSC Category

AN12 - Health R&D Services; Health Care Services; Applied Research

Federal Contract Vehicle

Set-Aside Type

Total Small Business

Extent Competed

Full and Open Competition after exclusion of sources

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Indianapolis, IN 46231, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Legislative Mandate

Service Contract Act

National Interest Action

Not listed

Research Type

SBIR Program Phase I Action

Primary Consortia Member

Not listed

This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases to Teichos Laboratories, LLC, a small business located in West Lafayette, IN. The $300,000 firm fixed price contract is for research on a novel TLR2 agonist-aluminum combination adjuvant to improve the quality and duration of the immune response. This SBIR contract was awarded under a solicitation that sought innovative research proposals from small businesses to address NIH and Centers for Disease Control and Prevention (CDC) mission needs across topics like infectious diseases, cancer, heart/lung health, and emerging pathogens. The contract is set aside for total small business participation.

Generated 5/22/24, 10:46 AM

Name	Solicitation Number	Federal Agency	Type	Posted Date (Click to sort descending)
Adjuvanted Virus-Mimicking Nanoparticle HIV Vaccine	PHS2021-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 4/6	7/2/21, 7:31 AM
Rapid Point of Care Test to Quantify HIV Drugs for Adherence Monitoring	PHS-2021-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 3/6	7/1/21, 2:36 PM
A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals	PHS-2021-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Solicitation 2/6	7/28/20, 1:40 PM
Nannovaccine for Eliciting 10E8-like bnAbs against HIV-1	PHS2021-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 5/6	7/2/21, 7:48 AM
A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals	PHS-2021-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Pre-Solicitation 1/6	7/9/20, 5:10 PM

Mod #	Reason For Modification	Federal Obligation (Click to sort descending)	Date (Click to sort ascending)
P00004	Other Administrative Action	$0	3/2/23
P00002	Other Administrative Action	$0	8/16/22
P00003	Other Administrative Action	$0	8/16/22
P00001	Other Administrative Action	$0	10/14/21
Not listed	Not listed	$300.0k	9/20/21

Plans
Login

Blog